The role of LLT1 in the liver and in hepatocellular carcinoma.

Norman Wolmark

NRG Oncology Network Group Operations Center

Liver and intrahepatic bile ducts

Radiation Oncology Surgery / Surgical oncology

Janet E Dancey

NCIC Clinical Trials Group - Canadian Collaborating Clinical Trials Network

Liver and intrahepatic bile ducts

Mark Thursz

Prolifica (Prevention of Liver Fibrosis and Cancer in Africa)

Liver and intrahepatic bile ducts

Pathology

Richard T D'Aquila

Third Coast Center for AIDS Research

Liver and intrahepatic bile ducts

Pathology

Demetrius Albanes

Heart Rate Consortium

Trachea, bronchus and lung Testis Stomach Prostate Pancreas Oesophagus Non-Hodgkin lymphoma Liver and intrahepatic bile ducts Leukaemia Larynx Kidney, renal pelvis and ureter Colorectum Brain, nervous system Bladder

John Tavis

Alpha Hydroxytropolones as HCC Preventatives

Liver and intrahepatic bile ducts

Pathology

Mitchell Ho

Development of antibody-based cancer therapies

Liver and intrahepatic bile ducts

Pathology

Investigator from University of Tübingen

Functional in vivo analysis of cholangiocarcinoma development, progression and metastasis

Liver and intrahepatic bile ducts

Dean W Felsher

Prognostic Metabolic Signatures of Cancers Through Mass Spectrometry Imaging

Non-Hodgkin lymphoma Liver and intrahepatic bile ducts Hodgkin lymphoma

Hematology and hematologic malignancies